Unfortunately the very existence of this presentation suggests Kilian and the board are thinking about raising funds again.
Lining up trial outcomes (real ones - not sites opened) against cash spend seems to be the sound thing to do analytically.
Looking at Kilian's history (past) of delivery against his chances of future performance seems prudent analytically too.
What has Kilian done since replacing Ross?
Ann: Investor Presentation, page-11
-
- There are more pages in this discussion • 604 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.015(6.82%) |
Mkt cap ! $42.48M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 22.0¢ | $67.82K | 299.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36363 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 14999 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |